(Z)-4-amino-N'-hydroxy-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,2,5-oxadiazole-3-carboximidamide

ID: ALA4483096

PubChem CID: 137297313

Max Phase: Preclinical

Molecular Formula: C13H15N5O2

Molecular Weight: 273.30

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nonc1/C(=N/O)NC1CCCc2ccccc21

Standard InChI:  InChI=1S/C13H15N5O2/c14-12-11(17-20-18-12)13(16-19)15-10-7-3-5-8-4-1-2-6-9(8)10/h1-2,4,6,10,19H,3,5,7H2,(H2,14,18)(H,15,16)

Standard InChI Key:  REYXPMSLAPYHAV-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 22  0  0  0  0  0  0  0  0999 V2000
    5.8441   -4.6721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6613   -4.6721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9157   -3.8953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2527   -3.4132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.5940   -3.8953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.1409   -5.3337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3629   -5.3326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5503   -5.2461    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6943   -6.0795    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.2132   -6.7400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2189   -4.4991    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7018   -3.8336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3736   -3.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5611   -2.9984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4069   -4.4094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0805   -3.6613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2712   -3.5711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7874   -4.2282    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1187   -4.9775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9271   -5.0641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  5  1  2  0
  2  6  1  0
  1  7  1  0
  7  8  1  0
  7  9  2  0
  9 10  1  0
  8 11  1  0
 11 12  1  0
 11 15  1  0
 12 13  1  0
 13 14  1  0
 14 16  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4483096

    ---

Associated Targets(Human)

IDO1 Tchem Indoleamine 2,3-dioxygenase (6650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 273.30Molecular Weight (Monoisotopic): 273.1226AlogP: 1.45#Rotatable Bonds: 2
Polar Surface Area: 109.56Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 6.94CX Basic pKa: CX LogP: 1.62CX LogD: 1.03
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.33Np Likeness Score: -1.04

References

1. Zhang H, Liu K, Pu Q, Achab A, Ardolino MJ, Cheng M, Deng Y, Doty AC, Ferguson H, Fradera X, Knemeyer I, Kurukulasuriya R, Lam YH, Lesburg CA, Martinot TA, McGowan MA, Miller JR, Otte K, Biju PJ, Sciammetta N, Solban N, Yu W, Zhou H, Wang X, Bennett DJ, Han Y..  (2019)  Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy.,  10  (11): [PMID:31749906] [10.1021/acsmedchemlett.9b00344]

Source